You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous stem cell transplant (ASCT)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Autologous Transplant, Myeloma Trial in Cleveland (Mycobiome Supporting Diet)

Not yet recruiting
  • Autologous Transplant
  • Myeloma
  • Mycobiome Supporting Diet
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 22, 2022

Systemic Lupus Erythematosus, Systemic Sclerosis Trial in Philadelphia (Depletion of CD3/CD19 in an autologous stem cell

Recruiting
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis
  • Depletion of CD3/CD19 in an autologous stem cell transplant
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
May 23, 2022

Multiple Myeloma Trial in Torino (Cyclophosphamide, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Division of Hematology, Molinette Hospital
Apr 6, 2022

Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • +3 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022

Multiple Myeloma Trial in New York (Tremelimumab, Durvalumab, Prevnar-13)

Terminated
Has Results
  • Multiple Myeloma
  • New York, New York
  • +1 more
Oct 3, 2022

Multiple Myeloma Trial in Hackensack (Pembrolizumab, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center-Hackensack Meridian Health
Jan 18, 2022

Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

Recruiting
  • Multiple Myeloma
  • +2 more
  • Wuhan, Hubei, China
    Institute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

Withdrawn
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Relapse Multiple Myeloma, Multiple Myeloma Trial in Brno, Ostrava, Praha (OPD5)

Withdrawn
  • Relapse Multiple Myeloma
  • Multiple Myeloma
  • Brno, Czechia
  • +2 more
Nov 17, 2021

Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

Completed
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +9 more
Sep 20, 2022

Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
May 4, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Adelaide, Australia
  • +51 more
Feb 16, 2022

Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

Not yet recruiting
  • Multiple Myeloma
  • Stem Cell Transplant Complications
  • PARE
  • Waitlist Control Group
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 30, 2023

Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)

Recruiting
  • Hodgkin's Lymphoma
  • Bydgoszcz, Poland
  • +12 more
Dec 23, 2021

Hodgkin Lymphoma, Adult, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Caba (Evaluation of

Recruiting
  • Hodgkin Lymphoma, Adult
  • +2 more
  • Evaluation of therapeutical approach after ASCT
  • Caba, Argentina
    FUNDALEU
Oct 1, 2021

Based on Maintenance Therapy Post Autologous Stem Cell

Recruiting
  • Multiple Myeloma
  • Autologous Stem Cell Transplant
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Jul 27, 2022

Myeloma Trial in Philadelphia (Belantamab mafodotin)

Recruiting
  • Myeloma
  • Belantamab mafodotin
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Jun 13, 2022

Multiple Myeloma Trial in Sweden, United States (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +8 more
Nov 23, 2021

Multiple Myeloma Trial in Little Rock (drug, procedure, biological)

Withdrawn
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jul 8, 2020

Multiple Myeloma Trial in Spain (Belantamab mafodotin, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +4 more
  • Sevilla, Andalucia, Spain
  • +17 more
Dec 3, 2021

Frontline of ASCT in High-risk DLBCL

Recruiting
  • Diffuse Large B Cell Lymphoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Apr 26, 2023

    ASCT Versus Chemotherapy as First-Line Consolidation Therapy

    Completed
    • T-cell Lymphoma Adults
    • consolidation with ASCT
    • (no location specified)
    Nov 25, 2023

    AL Amyloidosis Trial (procedure, drug, other)

    Not yet recruiting
    • AL Amyloidosis
    • Autologous Hematopoietic Stem Cell Transplantation
    • +15 more
    • (no location specified)
    Aug 28, 2023

    Lymphoma Trial in New York (rituximab, bendamustine, melphalan)

    Active, not recruiting
    • Lymphoma
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 10, 2023

    Multiple Myeloma Trial in Saint Petersburg (Melphalan, Nivolumab, Autologous Stem Cell Transplantation)

    Recruiting
    • Multiple Myeloma
    • Saint Petersburg, Russian Federation
      Boris V Afanasyev, MD, Prof.
    Apr 4, 2022